摘要
<正>肝门部胆管癌占胆管癌总体发病率的60%~70%,其对放化疗不敏感、预后差,根治性切除是目前唯一可能治愈手段~([1])。文献报道肝门部胆管癌5年存活率低,但是随着设备、技术的进步,治疗理念的更新,其DFS(disease-free survival)和OS(overall survival)均有明显改善,5年生存率可达到20%~40%~([1-2])。由于肝门部胆管癌毗邻结构复杂、手术难度大、风险高等原因,腹腔镜肝门胆管癌切除仅限
引文
[1]Rizvi S,Khan SA,Hallemeier CL,et al.Cholangiocarcinomaevolving concepts and therapeutic strategies[J].Nat Rev Clin Oncol,2018,15(2):95-111.
[2]Valle JW,Lamarca A,Goyal L,et al.New horizons for precision medicine in biliary tract cancers[J].Cancer Discov,2017,7(9):943-962.
[3]尹新民,刘雅玲,成伟,等.全腹腔镜IV型肝门部胆管癌根治术的临床应用价值(附视频)[J].中华肝脏外科手术学电子杂志,2018,7(2):110-114.
[4]朱鸿超,匡天佐,张福扬,等.全腹腔镜Bismuth I型肝门部胆管癌根治术7例[J].中国微创外科杂志,2018,18(3):274-276,288.
[5]杜羽升,赵文星,王骥,马红钦.完全腹腔镜手术治疗肝门部胆管癌(附6例报道)[J].中国普外基础与临床杂志,2017,24(12):1487-1491.
[6]Razumilava N,Gores GJ.Building a staircase to precision medicine for biliary tract cancer[J].Nat Genet,2015,47(9):967-968.
[7]Giuliante F,Ardito F,Guglielmi A,et al.Association of lymph node status with survival in patients after liver resection for hilar cholangiocarcinoma in an italian multicenter analysis[J].JAMA Surg,2016,151(10):916-922.
[8]杜成友,刘强.肝门胆管癌的术式选择[J].中国普外基础与临床杂志,2014,4(3):265-267.
[9]王坚.Bismuth IV型肝门胆管癌的治疗[J].肝胆胰外科杂志,2015,27(6):441-444.